Ryan D. Morrison
Molecular Sensing (United States)(US)Nashville Oncology Associates(US)
Publications by Year
Research Areas
Neuroscience and Neuropharmacology Research, Receptor Mechanisms and Signaling, Pharmacological Receptor Mechanisms and Effects, HER2/EGFR in Cancer Research, Lung Cancer Treatments and Mutations
Most-Cited Works
- → ML297 (VU0456810), the First Potent and Selective Activator of the GIRK Potassium Channel, Displays Antiepileptic Properties in Mice(2013)151 cited
- → Metabolism and Distribution of Clozapine-N-oxide: Implications for Nonhuman Primate Chemogenetics(2017)117 cited
- → Novel Allosteric Agonists of M1 Muscarinic Acetylcholine Receptors Induce Brain Region-Specific Responses That Correspond with Behavioral Effects in Animal Models(2012)112 cited
- → Potentiation of M1 Muscarinic Receptor Reverses Plasticity Deficits and Negative and Cognitive Symptoms in a Schizophrenia Mouse Model(2015)104 cited
- → The Metabotropic Glutamate Receptor 4-Positive Allosteric Modulator VU0364770 Produces Efficacy Alone and in Combination with l-DOPA or an Adenosine 2A Antagonist in Preclinical Rodent Models of Parkinson’s Disease(2011)99 cited
- → The Discovery and Characterization of ML218: A Novel, Centrally Active T-Type Calcium Channel Inhibitor with Robust Effects in STN Neurons and in a Rodent Model of Parkinson’s Disease(2011)